Indazole compounds useful as ketohexokinase inhibitors

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9771375
SERIAL NO

14338816

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention is directed to substituted indazole compounds, pharmaceutical compositions of these compounds and methods of use thereof. The compounds of the present invention are ketohexokinase (KHK) inhibitors, useful for treating or ameliorating a KHK mediated metabolic disorders and/or diseases such as obesity, Type II diabetes mellitus and Metabolic Syndrome X. In some embodiments, the substituted indazole compounds are of formula I, wherein R1-R3, Q, X, Y, Z, a, and b are defined herein.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
JANSSEN PHARMACEUTICA NVTURNHOUTESEWEG 30 BEERSE 2340

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Abad, Marta C Downingtown, US 5 6
Gibbs, Alan C Wyndmoor, US 9 11
Kuo, Gee-Hong Scotch Plains, US 67 598
Kuo, Lawrence C Gwynedd Valley, US 21 317
Song, Fengbin Princeton, US 12 45
Sui, Zhihua Norristown, US 129 723
Zhang, Xuqing Audubon, US 54 291

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Mar 26, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Mar 26, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00